Skip to Main Content

Paper Details

The influence of BRCA2 mutation on localized prostate cancer.
Nat Rev Urol
45
2019
BRCA2, BRCA2 mutation, BRCA2 mutations, BRCA2-mutant, BRCA2-mutant tumours, IDCP, Patients, ancestral clone, androgen, cancer, cancer cells, intraductal carcinoma of the prostate, invasive adenocarcinoma, localized prostate cancer, men, noncarrier tumours, patients, tumour, tumours
BRCA2 Protein, Humans, Male, Mutation, Prostatic Neoplasms
Author NameAffiliation
Renea A TaylorBiomedicine Discovery Institute, Monash University
Renea A TaylorPeter MacCallum Cancer Centre
Michael FraserOntario Institute for Cancer Research
Richard J RebelloCancer Research UK Manchester Institute, The University of Manchester, Manchester Cancer Research Centre
Paul C BoutrosOntario Institute for Cancer Research
Paul C BoutrosJonsson Comprehensive Cancer Center, University of California Los Angeles
Paul C BoutrosUniversity of California Los Angeles
Paul C BoutrosInstitute for Precision Health, University of California Los Angeles
Paul C BoutrosDavid Geffen School of Medicine, University of California Los Angeles
Paul C BoutrosDavid Geffen School of Medicine, University of California Los Angeles
Paul C BoutrosUniversity of Toronto
Paul C BoutrosUniversity of Toronto
Declan G MurphyThe University of Melbourne
Declan G MurphyPeter MacCallum Cancer Centre
Robert G BristowCancer Research UK Manchester Institute, The University of Manchester, Manchester Cancer Research Centre
Gail P RisbridgerThe University of Melbourne
Gail P RisbridgerBiomedicine Discovery Institute, Monash University
Gail P RisbridgerPeter MacCallum Cancer Centre
  • 1 - 18

Datasets

Release 1.2